Bausch Health Companies Inc BHC
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover BHC, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
Toronto Stocks Climb, Loblaw Shares Rise on 4Q Profit, Revenue Growth
-
Bausch Health Gets FDA Approval for Acne Treatment Cabtreo
-
Bausch Health shares fall after CFO resignation
-
Bausch Health CFO Tom Vadaketh to resign effective Oct. 13
-
Bausch Health's stock rallies after $600 million financing agreement with KKR
-
Bausch Health Shares Drop After Norwich Sues FDA for Final OK for Rival Drug
-
Bausch Health stock soars after company says rival application for generic version of its IBS drug can't be approved until 2029
Trading Information
- Previous Close Price
- CAD 10.27
- Day Range
- CAD 10.18–10.44
- 52-Week Range
- CAD 7.56–15.43
- Bid/Ask
- CAD 10.17 / CAD 10.36
- Market Cap
- CAD 3.74 Bil
- Volume/Avg
- 318,882 / 397,077
Key Statistics
- Price/Earnings (Normalized)
- 2.13
- Price/Sales
- 0.31
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 20,270
- Website
- https://www.bauschhealth.com
Comparables
Valuation
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Price/Earnings (Normalized) | 2.13 | 20.39 | 1.83 |
Price/Book Value | — | 0.80 | 0.75 |
Price/Sales | 0.31 | 1.23 | 0.51 |
Price/Cash Flow | 1.68 | 20.36 | 1.58 |
Price/Earnings
BHC
BLCO
ASRT
Financial Strength
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Quick Ratio | 0.63 | 0.76 | 1.30 |
Current Ratio | 1.22 | 1.70 | 1.83 |
Interest Coverage | 0.74 | 0.35 | −85.86 |
Quick Ratio
BHC
BLCO
ASRT
Profitability
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Return on Assets (Normalized) | 4.93% | 1.99% | −87.36% |
Return on Equity (Normalized) | — | 3.62% | −156.35% |
Return on Invested Capital (Normalized) | 9.78% | 4.10% | −128.46% |
Return on Assets
BHC
BLCO
ASRT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Ndlzcqbk | Bygq | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Fvwfqvctv | Ppfvtm | $71.9 Bil | |
HLN
| Haleon PLC ADR | Lmsgjwyg | Bwhhw | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jqnvnrql | Wbv | $15.6 Bil | |
VTRS
| Viatris Inc | Nncsdntpl | Gzrn | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Twhzmnjrd | Nhcjr | $12.5 Bil | |
CTLT
| Catalent Inc | Nnbscrkn | Wsclr | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Gstrlmcys | Sswg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rzygsnp | Pjkt | $3.9 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ndcqkpzy | Wwzhz | $3.5 Bil |